News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
202 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17605)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (21)
2 (28)
3 (291)
4 (299)
5 (210)
6 (198)
7 (88)
8 (20)
9 (26)
10 (204)
11 (264)
12 (223)
13 (206)
14 (127)
15 (5)
16 (12)
17 (183)
18 (268)
19 (197)
20 (202)
21 (95)
22 (5)
23 (6)
24 (193)
25 (218)
26 (195)
27 (217)
28 (97)
29 (2)
30 (3)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Deals
AbbVie Declares Quarterly Dividend Payable on August 15, 2019
The board of directors of AbbVie Inc. declared a quarterly cash dividend of $1.07 per share.
June 20, 2019
·
1 min read
BioMidwest
Battelle Is Announced a Finalist in the Department of Homeland Security’s Opioid Detection Challenge
Battelle has been announced as one of eight finalists in the Department of Homeland Security Science and Technology Directorate Opioid Detection Challenge, a $1.55 million global prize competition for rapid, nonintrusive detection tools that will help find illicit opioids in international mail.
June 20, 2019
·
3 min read
Job Trends
Matchwell Adds Annandale Village to Healthcare Job Marketplace in Georgia
Free Clinician Platform Now Available to Over Eighty Thousand Nurses in Georgia
June 20, 2019
·
2 min read
Business
Immunomic Therapeutics Announces Promotion of Teri Heiland, Ph.D. to Chief Scientific Officer
Immunomic Therapeutics, Inc. announced the promotion of Teri Heiland, Ph.D. to Chief Scientific Officer. In her new role, Dr. Heiland will oversee all of research and development and will play an integral role in business development and the management of ITI’s existing and future partnerships.
June 20, 2019
·
4 min read
Deals
Hologic Enters into Exclusive Negotiations to Acquire SuperSonic Imagine, French Ultrasound Innovator
Transaction Will Strengthen Hologic’s Breast Health Product Portfolio with Best-in-Class Technology Increasingly Used to Diagnose Cancer in Women with Dense Breasts
June 20, 2019
·
9 min read
Genetown
Novanta to Present at the CJS Securities 19th Annual “New Ideas” Summer Conference on Tuesday, July 9, 2019
Novanta Inc. announced that Robert Buckley, Chief Financial Officer, is scheduled to present at the CJS Securities 19th Annual “New Ideas” Summer Conference on Tuesday, July 9, 2019, in Greenwich, CT.
June 20, 2019
·
1 min read
Deals
HCP Prices $650 Million of 3.250% Senior Unsecured Notes due 2026 and $650 Million of 3.500% Senior Unsecured Notes due 2029
HCP, Inc. announced that it has priced a public offering of $650 million aggregate principal amount of 3.250% senior unsecured notes due 2026 and $650 million aggregate principal amount of 3.500% senior unsecured notes due 2029.
June 20, 2019
·
4 min read
Deals
Health Sciences Acquisitions Corporation Announces that Shares of Common Stock and Warrants to Commence Separate Trading on or about June 21, 2019
Health Sciences Acquisitions Corporation announced that holders of the Company’s units may elect to separately trade the common stock and warrants included in its units commencing on or about June 21, 2019.
June 20, 2019
·
2 min read
Policy
Recent FDA Inspection of KCAS Bioanalytical & Biomarker Services’ Kansas City, KS Facility is Successful with No 483s issued
Kansas-based KCAS said that its Shawnee Mission site, a bioanalytical testing laboratory facility, successfully completed a U.S. Food and Drug Administration general re-inspection conducted between June 10 and June 13, 2019.
June 20, 2019
·
2 min read
Business
Warrior Centric Health Awarded a Supplier Services Agreement for Veteran Population Health Services from Vizient, Inc.
Warrior Centric Health (WCH)® announces an agreement with Vizient, Inc. for the Warrior Centric Health Solution Suite™.
June 20, 2019
·
2 min read
Previous
5 of 21
Next